Allied Market Research

2026

Japan Orphan Drugs Market

Japan Orphan Drugs Market (2023-2032)

by DISEASE TYPE (ONCOLOGIC DISEASES, METABOLIC DISEASES, HEMATOLOGIC AND IMMUNOLOGIC DISEASES, INFECTIOUS DISEASES, NEUROLOGIC DISEASES, OTHER RARE DISEASES) and, by INDICATION (NON-HODGKIN LYMPHOMA, ACUTE MYELOID LEUKEMIA, CYSTIC FIBROSIS, GLIOMA, PANCREATIC CANCER, OVARIAN CANCER, MULTIPLE MYELOMA, DUCHENNE MUSCULAR DYSTROPHY, GRAFT VS HOST DISEASE, RENAL CELL CARCINOMA, Others)

LS : Pharmaceuticals

  • Feb 2026

  • Pages: NA

  • Tables: NA

  • Charts: NA

Select an option
Cloud Access (30% Off) $3,690 $2,583
Business User License (30% Off) $5,820 $4,074
Enterprise License (30% Off) $9,870 $6,909
Library Membership (15% Off) $1,175 $999
Enquiry Now
Author's: | Eswara Prasad
Publish Date:
Enquire Before Buying Customization Request Speak with Analyst

Get Sample to Email

  Japan Orphan Drugs Market Report Highlights

Aspects Details
icon_5
By DISEASE TYPE
  • ONCOLOGIC DISEASES
  • METABOLIC DISEASES
  • HEMATOLOGIC AND IMMUNOLOGIC DISEASES
  • INFECTIOUS DISEASES
  • NEUROLOGIC DISEASES
  • OTHER RARE DISEASES
icon_6
By INDICATION
  • NON-HODGKIN LYMPHOMA
  • ACUTE MYELOID LEUKEMIA
  • CYSTIC FIBROSIS
  • GLIOMA
  • PANCREATIC CANCER
  • OVARIAN CANCER
  • MULTIPLE MYELOMA
  • DUCHENNE MUSCULAR DYSTROPHY
  • GRAFT VS HOST DISEASE
  • RENAL CELL CARCINOMA
  • Others
icon_7
Key Market Players

Shionogi & Co., Ltd., Merck KGaA, Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Company, Limited, Pfizer, Inc., Kyowa Hakko Kirin Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Eisai Co., Ltd., Astellas Pharma Inc.

Loading Table Of Content...

*Terms and Conditions Apply

Japan Orphan Drugs Market

Global Opportunity Analysis and Industry Forecast, 2023-2032

help@alliedmarketresearch.com